Literature DB >> 21185283

Cell proliferation in the absence of E2F1-3.

Pamela L Wenzel1, Jean-Leon Chong, M Teresa Sáenz-Robles, Antoney Ferrey, John P Hagan, Yorman M Gomez, Ravi Rajmohan, Nidhi Sharma, Hui-Zi Chen, James M Pipas, Michael L Robinson, Gustavo Leone.   

Abstract

E2F transcription factors regulate the progression of the cell cycle by repression or transactivation of genes that encode cyclins, cyclin dependent kinases, checkpoint regulators, and replication proteins. Although some E2F functions are independent of the Retinoblastoma tumor suppressor (Rb) and related family members, p107 and p130, much of E2F-mediated repression of S phase entry is dependent upon Rb. We previously showed in cultured mouse embryonic fibroblasts that concomitant loss of three E2F activators with overlapping functions (E2F1, E2F2, and E2F3) triggered the p53-p21(Cip1) response and caused cell cycle arrest. Here we report on a dramatic difference in the requirement for E2F during development and in cultured cells by showing that cell cycle entry occurs normally in E2f1-3 triply-deficient epithelial stem cells and progenitors of the developing lens. Sixteen days after birth, however, massive apoptosis in differentiating epithelium leads to a collapse of the entire eye. Prior to this collapse, we find that expression of cell cycle-regulated genes in E2F-deficient lenses is aberrantly high. In a second set of experiments, we demonstrate that E2F3 ablation alone does not cause abnormalities in lens development but rescues phenotypic defects caused by loss of Rb, a binding partner of E2F known to recruit histone deacetylases, SWI/SNF and CtBP-polycomb complexes, methyltransferases, and other co-repressors to gene promoters. Together, these data implicate E2F1-3 in mediating transcriptional repression by Rb during cell cycle exit and point to a critical role for their repressive functions in cell survival. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21185283      PMCID: PMC3868453          DOI: 10.1016/j.ydbio.2010.12.025

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  42 in total

1.  Effects of an Rb mutation in the mouse.

Authors:  T Jacks; A Fazeli; E M Schmitt; R T Bronson; M A Goodell; R A Weinberg
Journal:  Nature       Date:  1992-09-24       Impact factor: 49.962

Review 2.  E2F target genes: unraveling the biology.

Authors:  Adrian P Bracken; Marco Ciro; Andrea Cocito; Kristian Helin
Journal:  Trends Biochem Sci       Date:  2004-08       Impact factor: 13.807

3.  Generalized lacZ expression with the ROSA26 Cre reporter strain.

Authors:  P Soriano
Journal:  Nat Genet       Date:  1999-01       Impact factor: 38.330

4.  Rb interacts with histone deacetylase to repress transcription.

Authors:  R X Luo; A A Postigo; D C Dean
Journal:  Cell       Date:  1998-02-20       Impact factor: 41.582

5.  Cluster analysis and display of genome-wide expression patterns.

Authors:  M B Eisen; P T Spellman; P O Brown; D Botstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

6.  Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kinetics.

Authors:  Aaron Aslanian; Phillip J Iaquinta; Raluca Verona; Jacqueline A Lees
Journal:  Genes Dev       Date:  2004-06-02       Impact factor: 11.361

7.  Identification of target genes of the p16INK4A-pRB-E2F pathway.

Authors:  Richard Vernell; Kristian Helin; Heiko Müller
Journal:  J Biol Chem       Date:  2003-08-15       Impact factor: 5.157

8.  PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes.

Authors:  Vamsi K Mootha; Cecilia M Lindgren; Karl-Fredrik Eriksson; Aravind Subramanian; Smita Sihag; Joseph Lehar; Pere Puigserver; Emma Carlsson; Martin Ridderstråle; Esa Laurila; Nicholas Houstis; Mark J Daly; Nick Patterson; Jill P Mesirov; Todd R Golub; Pablo Tamayo; Bruce Spiegelman; Eric S Lander; Joel N Hirschhorn; David Altshuler; Leif C Groop
Journal:  Nat Genet       Date:  2003-07       Impact factor: 38.330

9.  Aberrant lens fiber differentiation in anterior subcapsular cataract formation: a process dependent on reduced levels of Pax6.

Authors:  Frank J Lovicu; Philipp Steven; Shizuya Saika; John W McAvoy
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-06       Impact factor: 4.799

10.  Extracellular FGF-1 acts as a lens differentiation factor in transgenic mice.

Authors:  M L Robinson; P A Overbeek; D J Verran; W E Grizzle; C R Stockard; R Friesel; T Maciag; J A Thompson
Journal:  Development       Date:  1995-02       Impact factor: 6.868

View more
  30 in total

1.  Chromatin remodeling enzyme Snf2h regulates embryonic lens differentiation and denucleation.

Authors:  Shuying He; Saima Limi; Rebecca S McGreal; Qing Xie; Lisa A Brennan; Wanda Lee Kantorow; Juraj Kokavec; Romit Majumdar; Harry Hou; Winfried Edelmann; Wei Liu; Ruth Ashery-Padan; Jiri Zavadil; Marc Kantorow; Arthur I Skoultchi; Tomas Stopka; Ales Cvekl
Journal:  Development       Date:  2016-06-01       Impact factor: 6.868

Review 2.  Biomechanical force in blood development: extrinsic physical cues drive pro-hematopoietic signaling.

Authors:  Hyun Jung Lee; Nan Li; Siobahn M Evans; Miguel F Diaz; Pamela L Wenzel
Journal:  Differentiation       Date:  2013-07-12       Impact factor: 3.880

3.  Cellular transformation of mouse embryo fibroblasts in the absence of activator E2Fs.

Authors:  Tushar Gupta; Maria Teresa Sáenz Robles; James M Pipas
Journal:  J Virol       Date:  2015-02-25       Impact factor: 5.103

4.  Atypical E2F repressors and activators coordinate placental development.

Authors:  Madhu M Ouseph; Jing Li; Hui-Zi Chen; Thierry Pécot; Pamela Wenzel; John C Thompson; Grant Comstock; Veda Chokshi; Morgan Byrne; Braxton Forde; Jean-Leon Chong; Kun Huang; Raghu Machiraju; Alain de Bruin; Gustavo Leone
Journal:  Dev Cell       Date:  2012-04-17       Impact factor: 12.270

5.  E2f8 mediates tumor suppression in postnatal liver development.

Authors:  Lindsey N Kent; Jessica B Rakijas; Shusil K Pandit; Bart Westendorp; Hui-Zi Chen; Justin T Huntington; Xing Tang; Sooin Bae; Arunima Srivastava; Shantibhusan Senapati; Christopher Koivisto; Chelsea K Martin; Maria C Cuitino; Miguel Perez; Julian M Clouse; Veda Chokshi; Neelam Shinde; Raleigh Kladney; Daokun Sun; Antonio Perez-Castro; Ramadhan B Matondo; Sathidpak Nantasanti; Michal Mokry; Kun Huang; Raghu Machiraju; Soledad Fernandez; Thomas J Rosol; Vincenzo Coppola; Kamal S Pohar; James M Pipas; Carl R Schmidt; Alain de Bruin; Gustavo Leone
Journal:  J Clin Invest       Date:  2016-07-25       Impact factor: 14.808

6.  Ablation of the transcription factors E2F1-2 limits neuroinflammation and associated neurological deficits after contusive spinal cord injury.

Authors:  Junfang Wu; Boris Sabirzhanov; Bogdan A Stoica; Marta M Lipinski; Zaorui Zhao; Shuxin Zhao; Nicole Ward; Dianer Yang; Alan I Faden
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

7.  Impact of dynamin 2 on adenovirus nuclear entry.

Authors:  Ji Sun Lee; Ashrafali M Ismail; Jeong Yoon Lee; Xiaohong Zhou; Emma C Materne; James Chodosh; Jaya Rajaiya
Journal:  Virology       Date:  2019-01-10       Impact factor: 3.616

8.  E2F7 and E2F8 promote angiogenesis through transcriptional activation of VEGFA in cooperation with HIF1.

Authors:  Bart G M W Weijts; Walbert J Bakker; Peter W A Cornelissen; Kuo-Hsuan Liang; Frank H Schaftenaar; Bart Westendorp; Charlotte A C M T de Wolf; Maya Paciejewska; Colinda L G J Scheele; Lindsey Kent; Gustavo Leone; Stefan Schulte-Merker; Alain de Bruin
Journal:  EMBO J       Date:  2012-08-17       Impact factor: 11.598

Review 9.  The broken cycle: E2F dysfunction in cancer.

Authors:  Lindsey N Kent; Gustavo Leone
Journal:  Nat Rev Cancer       Date:  2019-06       Impact factor: 60.716

10.  A large multiethnic GWAS meta-analysis of cataract identifies new risk loci and sex-specific effects.

Authors:  Hélène Choquet; Ronald B Melles; Deepti Anand; Jie Yin; Gabriel Cuellar-Partida; Wei Wang; Thomas J Hoffmann; K Saidas Nair; Pirro G Hysi; Salil A Lachke; Eric Jorgenson
Journal:  Nat Commun       Date:  2021-06-14       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.